This inventor holds 5 USPTO granted patents. Top assignees: Lts Lohmann Therapie-Systeme Gmbh, Lts Lohmann Therapie-Systeme Ag. Active years: 1999-2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 54 
2 out of 334 
Years Active: 1999-2003
Title: Mirko Kreh: Innovator in Alkaloid Isolation
Introduction
Mirko Kreh is a notable inventor based in Marburg, Germany. He has made significant contributions to the field of alkaloid isolation, particularly through his innovative processes. With a total of five patents to his name, Kreh's work has implications for various medical treatments.
Latest Patents
One of Kreh's latest patents involves a process for the isolation of the alkaloid galanthamine. This invention not only details the method of isolation but also covers the galanthamine produced through this process. The galanthamine has potential applications in galenic preparations and is particularly useful for treating narrow-angle glaucoma, Alzheimer's disease, as well as alcohol and nicotine dependence.
Career Highlights
Throughout his career, Mirko Kreh has worked with prominent companies such as Lohmann Therapie-Systeme GmbH and Lohmann Therapie-Systeme AG. His experience in these organizations has contributed to his expertise in the field of pharmaceutical innovations.
Collaborations
Kreh has collaborated with notable colleagues, including Thomas Hille and Hans-Rainer Hoffmann. These partnerships have likely enriched his research and development efforts.
Conclusion
Mirko Kreh's contributions to the field of alkaloid isolation, particularly through his work on galanthamine, highlight his role as an influential inventor. His patents and collaborations reflect a commitment to advancing medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile